BioNTech Could Supply 3 Billion Covid Shots in 2022: CEO

The CEO of Biotech discusses the company's production capabilities, partnerships, and future plans. They are evaluating production based on market needs and have established a network with 13 partners. The goal is to produce enough vaccines to meet global demand by the end of 2022, with plans to increase capacity to 3 billion doses if needed. The company is confident in meeting these targets, provided there are no major production issues.

What are the potential challenges mentioned regarding vaccine production?

What is the expected manufacturing capacity for 2022 as discussed in the interview?